Apotex Health (APTX.TO) closed its upsized secondary offering of common shares by an affiliate of SK Capital Partners, API Investment LP and Allan Oberman, raising CA$850 million, it said in a statement on Friday.
The selling shareholders, pursuant to the offering, sold 25-million common shares at CA$34.00 apiece. The company did not receive any proceeds from the offering.
Shares of the company were last seen down 0.7% at CA$33.75 on the Toronto Stock Exchange.
Price: $33.76, Change: $-0.23, Percent Change: -0.68%